| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 27 |
| 1 | FINASTERIDE | 26 |
| 2 | METHOTREXATE | 24 |
| 3 | ALPRAZOLAM | 19 |
| 4 | LEVONORGESTREL | 19 |
| 5 | PAROXETINE HYDROCHLORIDE | 16 |
| 6 | MONTELUKAST | 15 |
| 7 | VENLAFAXINE HYDROCHLORIDE | 15 |
| 8 | CYCLOPHOSPHAMIDE | 14 |
| 9 | CYCLOPHOSPHAMIDE FOR INJECTION | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ESLICARBAZEPINE ACETATE | 5 | 0.0015 |
| 1 | BETAMETHASONE DIPROPIONATE | 7 | 0.0010 |
| 2 | PEGASPARGASE | 8 | 0.0006 |
| 3 | DAPTOMYCIN | 6 | 0.0006 |
| 4 | AXICABTAGENE CILOLEUCEL | 6 | 0.0006 |
| 5 | BRIVARACETAM | 5 | 0.0005 |
| 6 | NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) | 9 | 0.0005 |
| 7 | MERCAPTOPURINE | 8 | 0.0005 |
| 8 | PRAMIPEXOLE | 7 | 0.0004 |
| 9 | KETOPROFEN | 6 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 46 |
| 1 | Benzodiazepine [EPC] | 43 |
| 2 | 5-alpha Reductase Inhibitor [EPC] | 28 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 28 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 24 |
| 5 | Progestin [EPC] | 20 |
| 6 | Progestin-containing Intrauterine System [EPC] | 19 |
| 7 | Proton Pump Inhibitor [EPC] | 16 |
| 8 | Alkylating Drug [EPC] | 14 |
| 9 | Arteriolar Vasodilator [EPC] | 14 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lipopeptide Antibacterial [EPC] | 6 | 0.0006 |
| 1 | Asparagine-specific Enzyme [EPC] | 8 | 0.0006 |
| 2 | CD19-directed Chimeric Antigen Receptor [EPC] | 6 | 0.0006 |
| 3 | Nitrofuran Antibacterial [EPC] | 9 | 0.0005 |
| 4 | Provitamin D2 Compound [EPC] | 13 | 0.0004 |
| 5 | Thyroid Hormone Receptor beta Agonist [EPC] | 1 | 0.0004 |
| 6 | Nonergot Dopamine Agonist [EPC] | 6 | 0.0004 |
| 7 | 5-alpha Reductase Inhibitor [EPC] | 28 | 0.0003 |
| 8 | Anti-coagulant [EPC] | 1 | 0.0003 |
| 9 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |